Royal Bank of Canada
CELL

Royal Bank of Canada’s PhenomeX Inc. Common Stock CELL Stock Holding History

Royal Bank of Canada’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-383
Closed – – 7898
2023
Q3 		$0 Sell
383
-2,151
-85% -$1.65K ﹤0.01% 7871
2023
Q2 		$1K Sell
2,534
-1,228
-33% -$1K ﹤0.01% 7171
2023
Q1 		$4K Sell
3,762
-6,098
-62% -$11.1K ﹤0.01% 6655
2022
Q4 		$27K Buy
9,860
+5,830
+145% +$15.4K ﹤0.01% 6188
2022
Q3 		$12K Buy
4,030
+3,353
+495% +$14.3K ﹤0.01% 6365
2022
Q2 		$4K Sell
677
-3,107
-82% -$16.3K ﹤0.01% 6782
2022
Q1 		$27K Sell
3,784
-41,574
-92% -$344K ﹤0.01% 6454
2021
Q4 		$825K Buy
45,358
+41,252
+1,005% +$890K ﹤0.01% 4011
2021
Q3 		$81K Sell
4,106
-45,460
-92% -$1.73M ﹤0.01% 5853
2021
Q2 		$2.22M Buy
49,566
+16,735
+51% +$776K ﹤0.01% 2967
2021
Q1 		$1.65M Buy
32,831
+26,847
+449% +$1.83M ﹤0.01% 3159
2020
Q4 		$535K Buy
5,984
+5,645
+1,665% +$475K ﹤0.01% 4078
2020
Q3 		$26K Buy
+339
New +$21.5K ﹤0.01% 5599

Royal Bank of Canada's CELL Position: Q4 2023 in Review

Royal Bank of Canada sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 383 shares.

Royal Bank of Canada first reported a position in CELL in Q3 2020 and held it in 13 quarters. The position peaked at $2.22M in Q2 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • Royal Bank of Canada reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 383 PhenomeX Inc. Common Stock shares in Q4 2023.
  • Royal Bank of Canada first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 13 quarters.
  • Royal Bank of Canada's PhenomeX Inc. Common Stock position peaked at $2.22M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.